0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Lansoprazole for Injection Market Research Report 2026
Published Date: 2026-03-04
|
Report Code: QYRE-Auto-26O17432
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Lansoprazole for Injection Market Research Report 2024
BUY CHAPTERS

Global Lansoprazole for Injection Market Research Report 2026

Code: QYRE-Auto-26O17432
Report
2026-03-04
Pages:111
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Lansoprazole for Injection Market Size

The global Lansoprazole for Injection market was valued at US$ 223 million in 2025 and is anticipated to reach US$ 385 million by 2032, at a CAGR of 8.2% from 2026 to 2032.

Lansoprazole for Injection Market

Lansoprazole for Injection Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Lansoprazole for Injection competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Lansoprazole injection is a formulation of the medication lansoprazole that is administered intravenously (IV) or intramuscularly (IM). Lansoprazole is a proton pump inhibitor (PPI) that works by reducing the amount of acid produced in the stomach. It is commonly used to treat conditions such as ulcers, gastroesophageal reflux disease (GERD), and Zollinger-Ellison syndrome.
The North American market for Lansoprazole for Injection is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Lansoprazole for Injection is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Lansoprazole for Injection include Takeda, Maya Biotech, Luoxin Pharmaceutical, Yuekang Pharmaceutical, Jiangsu Aosaikang Pharmaceutical, Chengdu Baiyu Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Lansoprazole for Injection market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Lansoprazole for Injection. The Lansoprazole for Injection market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Lansoprazole for Injection market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Lansoprazole for Injection manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Lansoprazole for Injection Market Report

Report Metric Details
Report Name Lansoprazole for Injection Market
Accounted market size in 2025 US$ 223 million
Forecasted market size in 2032 US$ 385 million
CAGR 8.2%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Vial Type
  • Ampule Type
by Application
  • Male
  • Female
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Takeda, Maya Biotech, Luoxin Pharmaceutical, Yuekang Pharmaceutical, Jiangsu Aosaikang Pharmaceutical, Chengdu Baiyu Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Lansoprazole for Injection manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Lansoprazole for Injection sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Lansoprazole for Injection Market growing?

Ans: The Lansoprazole for Injection Market witnessing a CAGR of 8.2% during the forecast period 2026-2032.

What is the Lansoprazole for Injection Market size in 2032?

Ans: The Lansoprazole for Injection Market size in 2032 will be US$ 385 million.

Who are the main players in the Lansoprazole for Injection Market report?

Ans: The main players in the Lansoprazole for Injection Market are Takeda, Maya Biotech, Luoxin Pharmaceutical, Yuekang Pharmaceutical, Jiangsu Aosaikang Pharmaceutical, Chengdu Baiyu Pharmaceutical

What are the Application segmentation covered in the Lansoprazole for Injection Market report?

Ans: The Applications covered in the Lansoprazole for Injection Market report are Male, Female

What are the Type segmentation covered in the Lansoprazole for Injection Market report?

Ans: The Types covered in the Lansoprazole for Injection Market report are Vial Type, Ampule Type

1 Lansoprazole for Injection Market Overview
1.1 Product Definition
1.2 Lansoprazole for Injection by Type
1.2.1 Global Lansoprazole for Injection Market Value by Type: 2025 vs 2032
1.2.2 Vial Type
1.2.3 Ampule Type
1.3 Lansoprazole for Injection by Application
1.3.1 Global Lansoprazole for Injection Market Value by Application: 2025 vs 2032
1.3.2 Male
1.3.3 Female
1.4 Global Lansoprazole for Injection Market Size Estimates and Forecasts
1.4.1 Global Lansoprazole for Injection Revenue 2021–2032
1.4.2 Global Lansoprazole for Injection Sales 2021–2032
1.4.3 Global Lansoprazole for Injection Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Lansoprazole for Injection Market Competition by Manufacturers
2.1 Global Lansoprazole for Injection Sales Market Share by Manufacturers (2021–2026)
2.2 Global Lansoprazole for Injection Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Lansoprazole for Injection Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Lansoprazole for Injection, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Lansoprazole for Injection, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Lansoprazole for Injection, Product Types and Applications
2.7 Global Key Manufacturers of Lansoprazole for Injection, Date of Entry into the Industry
2.8 Global Lansoprazole for Injection Market Competitive Situation and Trends
2.8.1 Global Lansoprazole for Injection Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Lansoprazole for Injection Players Market Share by Revenue
2.8.3 Global Lansoprazole for Injection Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Lansoprazole for Injection Market Scenario by Region
3.1 Global Lansoprazole for Injection Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Lansoprazole for Injection Sales by Region: 2021–2032
3.2.1 Global Lansoprazole for Injection Sales by Region: 2021–2026
3.2.2 Global Lansoprazole for Injection Sales by Region: 2027–2032
3.3 Global Lansoprazole for Injection Revenue by Region: 2021–2032
3.3.1 Global Lansoprazole for Injection Revenue by Region: 2021–2026
3.3.2 Global Lansoprazole for Injection Revenue by Region: 2027–2032
3.4 North America Lansoprazole for Injection Market Facts & Figures by Country
3.4.1 North America Lansoprazole for Injection Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Lansoprazole for Injection Sales by Country (2021–2032)
3.4.3 North America Lansoprazole for Injection Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Lansoprazole for Injection Market Facts & Figures by Country
3.5.1 Europe Lansoprazole for Injection Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Lansoprazole for Injection Sales by Country (2021–2032)
3.5.3 Europe Lansoprazole for Injection Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Lansoprazole for Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Lansoprazole for Injection Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Lansoprazole for Injection Sales by Region (2021–2032)
3.6.3 Asia Pacific Lansoprazole for Injection Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Lansoprazole for Injection Market Facts & Figures by Country
3.7.1 Latin America Lansoprazole for Injection Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Lansoprazole for Injection Sales by Country (2021–2032)
3.7.3 Latin America Lansoprazole for Injection Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Lansoprazole for Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Lansoprazole for Injection Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Lansoprazole for Injection Sales by Country (2021–2032)
3.8.3 Middle East and Africa Lansoprazole for Injection Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Lansoprazole for Injection Sales by Type (2021–2032)
4.1.1 Global Lansoprazole for Injection Sales by Type (2021–2026)
4.1.2 Global Lansoprazole for Injection Sales by Type (2027–2032)
4.1.3 Global Lansoprazole for Injection Sales Market Share by Type (2021–2032)
4.2 Global Lansoprazole for Injection Revenue by Type (2021–2032)
4.2.1 Global Lansoprazole for Injection Revenue by Type (2021–2026)
4.2.2 Global Lansoprazole for Injection Revenue by Type (2027–2032)
4.2.3 Global Lansoprazole for Injection Revenue Market Share by Type (2021–2032)
4.3 Global Lansoprazole for Injection Price by Type (2021–2032)
5 Segment by Application
5.1 Global Lansoprazole for Injection Sales by Application (2021–2032)
5.1.1 Global Lansoprazole for Injection Sales by Application (2021–2026)
5.1.2 Global Lansoprazole for Injection Sales by Application (2027–2032)
5.1.3 Global Lansoprazole for Injection Sales Market Share by Application (2021–2032)
5.2 Global Lansoprazole for Injection Revenue by Application (2021–2032)
5.2.1 Global Lansoprazole for Injection Revenue by Application (2021–2026)
5.2.2 Global Lansoprazole for Injection Revenue by Application (2027–2032)
5.2.3 Global Lansoprazole for Injection Revenue Market Share by Application (2021–2032)
5.3 Global Lansoprazole for Injection Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Takeda
6.1.1 Takeda Company Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda Lansoprazole for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Takeda Lansoprazole for Injection Product Portfolio
6.1.5 Takeda Recent Developments/Updates
6.2 Maya Biotech
6.2.1 Maya Biotech Company Information
6.2.2 Maya Biotech Description and Business Overview
6.2.3 Maya Biotech Lansoprazole for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Maya Biotech Lansoprazole for Injection Product Portfolio
6.2.5 Maya Biotech Recent Developments/Updates
6.3 Luoxin Pharmaceutical
6.3.1 Luoxin Pharmaceutical Company Information
6.3.2 Luoxin Pharmaceutical Description and Business Overview
6.3.3 Luoxin Pharmaceutical Lansoprazole for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Luoxin Pharmaceutical Lansoprazole for Injection Product Portfolio
6.3.5 Luoxin Pharmaceutical Recent Developments/Updates
6.4 Yuekang Pharmaceutical
6.4.1 Yuekang Pharmaceutical Company Information
6.4.2 Yuekang Pharmaceutical Description and Business Overview
6.4.3 Yuekang Pharmaceutical Lansoprazole for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Yuekang Pharmaceutical Lansoprazole for Injection Product Portfolio
6.4.5 Yuekang Pharmaceutical Recent Developments/Updates
6.5 Jiangsu Aosaikang Pharmaceutical
6.5.1 Jiangsu Aosaikang Pharmaceutical Company Information
6.5.2 Jiangsu Aosaikang Pharmaceutical Description and Business Overview
6.5.3 Jiangsu Aosaikang Pharmaceutical Lansoprazole for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Jiangsu Aosaikang Pharmaceutical Lansoprazole for Injection Product Portfolio
6.5.5 Jiangsu Aosaikang Pharmaceutical Recent Developments/Updates
6.6 Chengdu Baiyu Pharmaceutical
6.6.1 Chengdu Baiyu Pharmaceutical Company Information
6.6.2 Chengdu Baiyu Pharmaceutical Description and Business Overview
6.6.3 Chengdu Baiyu Pharmaceutical Lansoprazole for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Chengdu Baiyu Pharmaceutical Lansoprazole for Injection Product Portfolio
6.6.5 Chengdu Baiyu Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Lansoprazole for Injection Industry Chain Analysis
7.2 Lansoprazole for Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Lansoprazole for Injection Production Mode & Process Analysis
7.4 Lansoprazole for Injection Sales and Marketing
7.4.1 Lansoprazole for Injection Sales Channels
7.4.2 Lansoprazole for Injection Distributors
7.5 Lansoprazole for Injection Customer Analysis
8 Lansoprazole for Injection Market Dynamics
8.1 Lansoprazole for Injection Industry Trends
8.2 Lansoprazole for Injection Market Drivers
8.3 Lansoprazole for Injection Market Challenges
8.4 Lansoprazole for Injection Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Lansoprazole for Injection Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Lansoprazole for Injection Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Lansoprazole for Injection Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Lansoprazole for Injection Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Lansoprazole for Injection Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Lansoprazole for Injection Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Lansoprazole for Injection Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Lansoprazole for Injection Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Lansoprazole for Injection, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Lansoprazole for Injection, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Lansoprazole for Injection, Product Types and Applications
 Table 12. Global Key Manufacturers of Lansoprazole for Injection, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Lansoprazole for Injection Companies by Tier (Tier 1, Tier 2, Tier 3), based on Lansoprazole for Injection Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Lansoprazole for Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Lansoprazole for Injection Sales by Region (K Units), 2021–2026
 Table 18. Global Lansoprazole for Injection Sales Market Share by Region (2021–2026)
 Table 19. Global Lansoprazole for Injection Sales by Region (K Units), 2027–2032
 Table 20. Global Lansoprazole for Injection Sales Market Share by Region (2027–2032)
 Table 21. Global Lansoprazole for Injection Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Lansoprazole for Injection Revenue Market Share by Region (2021–2026)
 Table 23. Global Lansoprazole for Injection Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Lansoprazole for Injection Revenue Market Share by Region (2027–2032)
 Table 25. North America Lansoprazole for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Lansoprazole for Injection Sales by Country (K Units), 2021–2026
 Table 27. North America Lansoprazole for Injection Sales by Country (K Units), 2027–2032
 Table 28. North America Lansoprazole for Injection Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Lansoprazole for Injection Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Lansoprazole for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Lansoprazole for Injection Sales by Country (K Units), 2021–2026
 Table 32. Europe Lansoprazole for Injection Sales by Country (K Units), 2027–2032
 Table 33. Europe Lansoprazole for Injection Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Lansoprazole for Injection Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Lansoprazole for Injection Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Lansoprazole for Injection Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Lansoprazole for Injection Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Lansoprazole for Injection Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Lansoprazole for Injection Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Lansoprazole for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Lansoprazole for Injection Sales by Country (K Units), 2021–2026
 Table 42. Latin America Lansoprazole for Injection Sales by Country (K Units), 2027–2032
 Table 43. Latin America Lansoprazole for Injection Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Lansoprazole for Injection Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Lansoprazole for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Lansoprazole for Injection Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Lansoprazole for Injection Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Lansoprazole for Injection Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Lansoprazole for Injection Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Lansoprazole for Injection Sales (K Units) by Type (2021–2026)
 Table 51. Global Lansoprazole for Injection Sales (K Units) by Type (2027–2032)
 Table 52. Global Lansoprazole for Injection Sales Market Share by Type (2021–2026)
 Table 53. Global Lansoprazole for Injection Sales Market Share by Type (2027–2032)
 Table 54. Global Lansoprazole for Injection Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Lansoprazole for Injection Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Lansoprazole for Injection Revenue Market Share by Type (2021–2026)
 Table 57. Global Lansoprazole for Injection Revenue Market Share by Type (2027–2032)
 Table 58. Global Lansoprazole for Injection Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Lansoprazole for Injection Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Lansoprazole for Injection Sales (K Units) by Application (2021–2026)
 Table 61. Global Lansoprazole for Injection Sales (K Units) by Application (2027–2032)
 Table 62. Global Lansoprazole for Injection Sales Market Share by Application (2021–2026)
 Table 63. Global Lansoprazole for Injection Sales Market Share by Application (2027–2032)
 Table 64. Global Lansoprazole for Injection Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Lansoprazole for Injection Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Lansoprazole for Injection Revenue Market Share by Application (2021–2026)
 Table 67. Global Lansoprazole for Injection Revenue Market Share by Application (2027–2032)
 Table 68. Global Lansoprazole for Injection Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Lansoprazole for Injection Price (US$/Unit) by Application (2027–2032)
 Table 70. Takeda Company Information
 Table 71. Takeda Description and Business Overview
 Table 72. Takeda Lansoprazole for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Takeda Lansoprazole for Injection Product
 Table 74. Takeda Recent Developments/Updates
 Table 75. Maya Biotech Company Information
 Table 76. Maya Biotech Description and Business Overview
 Table 77. Maya Biotech Lansoprazole for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Maya Biotech Lansoprazole for Injection Product
 Table 79. Maya Biotech Recent Developments/Updates
 Table 80. Luoxin Pharmaceutical Company Information
 Table 81. Luoxin Pharmaceutical Description and Business Overview
 Table 82. Luoxin Pharmaceutical Lansoprazole for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Luoxin Pharmaceutical Lansoprazole for Injection Product
 Table 84. Luoxin Pharmaceutical Recent Developments/Updates
 Table 85. Yuekang Pharmaceutical Company Information
 Table 86. Yuekang Pharmaceutical Description and Business Overview
 Table 87. Yuekang Pharmaceutical Lansoprazole for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Yuekang Pharmaceutical Lansoprazole for Injection Product
 Table 89. Yuekang Pharmaceutical Recent Developments/Updates
 Table 90. Jiangsu Aosaikang Pharmaceutical Company Information
 Table 91. Jiangsu Aosaikang Pharmaceutical Description and Business Overview
 Table 92. Jiangsu Aosaikang Pharmaceutical Lansoprazole for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Jiangsu Aosaikang Pharmaceutical Lansoprazole for Injection Product
 Table 94. Jiangsu Aosaikang Pharmaceutical Recent Developments/Updates
 Table 95. Chengdu Baiyu Pharmaceutical Company Information
 Table 96. Chengdu Baiyu Pharmaceutical Description and Business Overview
 Table 97. Chengdu Baiyu Pharmaceutical Lansoprazole for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Chengdu Baiyu Pharmaceutical Lansoprazole for Injection Product
 Table 99. Chengdu Baiyu Pharmaceutical Recent Developments/Updates
 Table 100. Key Raw Materials Lists
 Table 101. Raw Materials Key Suppliers Lists
 Table 102. Lansoprazole for Injection Distributors List
 Table 103. Lansoprazole for Injection Customers List
 Table 104. Lansoprazole for Injection Market Trends
 Table 105. Lansoprazole for Injection Market Drivers
 Table 106. Lansoprazole for Injection Market Challenges
 Table 107. Lansoprazole for Injection Market Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Lansoprazole for Injection
 Figure 2. Global Lansoprazole for Injection Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Lansoprazole for Injection Market Share by Type: 2025 & 2032
 Figure 4. Vial Type Product Picture
 Figure 5. Ampule Type Product Picture
 Figure 6. Global Lansoprazole for Injection Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Lansoprazole for Injection Market Share by Application: 2025 & 2032
 Figure 8. Male
 Figure 9. Female
 Figure 10. Global Lansoprazole for Injection Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 11. Global Lansoprazole for Injection Market Size (US$ Million), 2021–2032
 Figure 12. Global Lansoprazole for Injection Sales (K Units), 2021–2032
 Figure 13. Global Lansoprazole for Injection Average Price (US$/Unit), 2021–2032
 Figure 14. Lansoprazole for Injection Report Years Considered
 Figure 15. Lansoprazole for Injection Sales Share by Manufacturers in 2025
 Figure 16. Global Lansoprazole for Injection Revenue Share by Manufacturers in 2025
 Figure 17. Top 5 and Top 10 Global Lansoprazole for Injection Players: Market Share by Revenue in Lansoprazole for Injection in 2025
 Figure 18. Lansoprazole for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 19. Global Lansoprazole for Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 20. North America Lansoprazole for Injection Sales Market Share by Country (2021–2032)
 Figure 21. North America Lansoprazole for Injection Revenue Market Share by Country (2021–2032)
 Figure 22. United States Lansoprazole for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 23. Canada Lansoprazole for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Europe Lansoprazole for Injection Sales Market Share by Country (2021–2032)
 Figure 25. Europe Lansoprazole for Injection Revenue Market Share by Country (2021–2032)
 Figure 26. Germany Lansoprazole for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. France Lansoprazole for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. U.K. Lansoprazole for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. Italy Lansoprazole for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Russia Lansoprazole for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Asia Pacific Lansoprazole for Injection Sales Market Share by Region (2021–2032)
 Figure 32. Asia Pacific Lansoprazole for Injection Revenue Market Share by Region (2021–2032)
 Figure 33. China Lansoprazole for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Japan Lansoprazole for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. South Korea Lansoprazole for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. India Lansoprazole for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Australia Lansoprazole for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. China Taiwan Lansoprazole for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Southeast Asia Lansoprazole for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Latin America Lansoprazole for Injection Sales Market Share by Country (2021–2032)
 Figure 41. Latin America Lansoprazole for Injection Revenue Market Share by Country (2021–2032)
 Figure 42. Mexico Lansoprazole for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Brazil Lansoprazole for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Argentina Lansoprazole for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Colombia Lansoprazole for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Middle East and Africa Lansoprazole for Injection Sales Market Share by Country (2021–2032)
 Figure 47. Middle East and Africa Lansoprazole for Injection Revenue Market Share by Country (2021–2032)
 Figure 48. Turkey Lansoprazole for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Saudi Arabia Lansoprazole for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. UAE Lansoprazole for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Global Sales Market Share of Lansoprazole for Injection by Type (2021–2032)
 Figure 52. Global Revenue Market Share of Lansoprazole for Injection by Type (2021–2032)
 Figure 53. Global Lansoprazole for Injection Price (US$/Unit) by Type (2021–2032)
 Figure 54. Global Sales Market Share of Lansoprazole for Injection by Application (2021–2032)
 Figure 55. Global Revenue Market Share of Lansoprazole for Injection by Application (2021–2032)
 Figure 56. Global Lansoprazole for Injection Price (US$/Unit) by Application (2021–2032)
 Figure 57. Lansoprazole for Injection Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network